Dr. Carl Anthony Labella Iii is a Jbsa Lackland, Texas based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland. Patients can reach him at 210-292-5125.
Dr. Carl Anthony Labella Iii deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Carl Anthony Labella Iii speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Carl Anthony Labella Iii
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
D D S
Accepts Medicare Assignment:
May Accept
Practice Address:
1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, Texas, 78236
Phone:
210-292-5125
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
3476707308
Enrollment ID:
I20130131000196
NPI Number:
1881683530
NPI Enumeration Date:
17 Oct, 2005
NPI Last Update On:
10 Feb, 2021
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, Texas
Zip:
78236-5638
Phone Number:
210-292-5125
Patients can reach Dr. Carl Anthony Labella Iii at 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, Texas or can call to book an appointment on 210-292-5125. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.